(CHPT) ChargePoint Holdings - Overview
Stock: Charging Stations, Network Software, Cloud Services
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 100% |
| Relative Tail Risk | -9.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.07 |
| Alpha | -89.36 |
| Character TTM | |
|---|---|
| Beta | 1.591 |
| Beta Downside | 0.822 |
| Drawdowns 3y | |
|---|---|
| Max DD | 97.91% |
| CAGR/Max DD | -0.72 |
Description: CHPT ChargePoint Holdings December 29, 2025
ChargePoint Holdings, Inc. (NYSE: CHPT) operates EV-charging networks and hardware across North America and Europe, targeting three core customer segments: commercial sites (retail, workplaces, hospitality, healthcare, fueling stations, parking facilities), fleet operators (municipal buses, delivery vans, airport/port/warehouse fleets, ride-share services), and residential users (single-family homes and multi-family apartments/condominiums). Founded in 2007 and headquartered in Campbell, California, the firm is classified under the Electrical Components & Equipment sub-industry.
Key metrics as of Q3 2024 show the company’s network exceeded 210,000 charging ports, with a 27 % year-over-year increase in active session volume, reflecting accelerating EV adoption. Revenue growth is being driven primarily by recurring subscription services (network access, software analytics) that now represent roughly 45 % of total sales, while hardware sales remain a smaller, more volatile component. A material sector driver is the expanding U.S. federal tax credit for EV infrastructure (up to $7,500 per charger) and the European Union’s “Fit-for-55” emissions package, both of which are expected to boost capital spending on public and private charging assets.
For a deeper, data-rich assessment of CHPT’s valuation and risk profile, you may find ValueRay’s analytical dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -234.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA 12.55 > 1.0 |
| NWC/Revenue: 47.20% < 20% (prev 69.63%; Δ -22.42% < -1%) |
| CFO/TA -0.08 > 3% & CFO -64.3m > Net Income -234.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.2m) vs 12m ago 6.68% < -2% |
| Gross Margin: 29.69% > 18% (prev 0.22%; Δ 2947 % > 0.5%) |
| Asset Turnover: 44.51% > 50% (prev 44.60%; Δ -0.09% > 0%) |
| Interest Coverage Ratio: -8.83 > 6 (EBITDA TTM -178.3m / Interest Expense TTM 23.5m) |
Altman Z'' -10.69
| A: 0.22 (Total Current Assets 516.1m - Total Current Liabilities 325.5m) / Total Assets 848.0m |
| B: -2.44 (Retained Earnings -2.07b / Total Assets 848.0m) |
| C: -0.23 (EBIT TTM -207.6m / Avg Total Assets 907.2m) |
| D: -2.55 (Book Value of Equity -2.07b / Total Liabilities 809.6m) |
| Altman-Z'' Score: -10.69 = D |
Beneish M -3.49
| DSRI: 0.93 (Receivables 97.1m/111.9m, Revenue 403.8m/431.0m) |
| GMI: 0.74 (GM 29.69% / 22.04%) |
| AQI: 1.14 (AQ_t 0.35 / AQ_t-1 0.30) |
| SGI: 0.94 (Revenue 403.8m / 431.0m) |
| TATA: -0.20 (NI -234.6m - CFO -64.3m) / TA 848.0m) |
| Beneish M-Score: -3.49 (Cap -4..+1) = AA |
What is the price of CHPT shares?
Over the past week, the price has changed by +7.22%, over one month by -13.37%, over three months by -37.67% and over the past year by -61.46%.
Is CHPT a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 12
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the CHPT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.2 | 67.3% |
| Analysts Target Price | 10.2 | 67.3% |
| ValueRay Target Price | 2.1 | -65.7% |
CHPT Fundamental Data Overview February 04, 2026
P/B = 3.6913
Revenue TTM = 403.8m USD
EBIT TTM = -207.6m USD
EBITDA TTM = -178.3m USD
Long Term Debt = 321.8m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 12.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -168.6m USD (from netDebt column, last quarter)
Enterprise Value = -34.2m USD (134.3m + Debt 12.0m - CCE 180.5m)
Interest Coverage Ratio = -8.83 (Ebit TTM -207.6m / Interest Expense TTM 23.5m)
EV/FCF = 0.49x (Enterprise Value -34.2m / FCF TTM -69.6m)
FCF Yield = 203.6% (FCF TTM -69.6m / Enterprise Value -34.2m)
FCF Margin = -17.25% (FCF TTM -69.6m / Revenue TTM 403.8m)
Net Margin = -58.09% (Net Income TTM -234.6m / Revenue TTM 403.8m)
Gross Margin = 29.69% ((Revenue TTM 403.8m - Cost of Revenue TTM 283.9m) / Revenue TTM)
Gross Margin QoQ = 30.74% (prev 31.17%)
Tobins Q-Ratio = -0.04 (set to none) (Enterprise Value -34.2m / Total Assets 848.0m)
Interest Expense / Debt = 67.38% (Interest Expense 8.06m / Debt 12.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -164.0m (EBIT -207.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.59 (Total Current Assets 516.1m / Total Current Liabilities 325.5m)
Debt / Equity = 0.31 (Debt 12.0m / totalStockholderEquity, last quarter 38.4m)
Debt / EBITDA = 0.95 (negative EBITDA) (Net Debt -168.6m / EBITDA -178.3m)
Debt / FCF = 2.42 (negative FCF - burning cash) (Net Debt -168.6m / FCF TTM -69.6m)
Total Stockholder Equity = 91.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -25.86% (Net Income -234.6m / Total Assets 848.0m)
RoE = -257.0% (Net Income TTM -234.6m / Total Stockholder Equity 91.3m)
RoCE = -50.26% (EBIT -207.6m / Capital Employed (Equity 91.3m + L.T.Debt 321.8m))
RoIC = -40.97% (negative operating profit) (NOPAT -164.0m / Invested Capital 400.3m)
WACC = 10.82% (E(134.3m)/V(146.3m) * Re(11.78%) + (debt cost/tax rate unavailable))
Discount Rate = 11.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.11%
Fair Price DCF = unknown (Cash Flow -69.6m)
EPS Correlation: 76.51 | EPS CAGR: 16.59% | SUE: -0.02 | # QB: 0
Revenue Correlation: -3.90 | Revenue CAGR: 7.46% | SUE: 1.42 | # QB: 1
EPS next Quarter (2026-04-30): EPS=-1.02 | Chg30d=+0.121 | Revisions Net=+2 | Analysts=2
EPS next Year (2027-01-31): EPS=-3.45 | Chg30d=+0.163 | Revisions Net=+0 | Growth EPS=+31.9% | Growth Revenue=+8.7%